Cactus, Inc. (WHD) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.95%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.95% | Share-based compensation / revenue. Period ending 2026-06-30. $26.56M ÷ $1.36B × 100 ≈ 1.95% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.36B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 26.56M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 254.17M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.36B | $26.56M | $254.17M | (m) | (m) | 1.95% | (m) | (m) |
| 2026-03-31 | (m) | $1.19B | $25.47M | $231.39M | (m) | (m) | 2.15% | (m) | (m) |
| 2025-12-31 | (m) | $1.08B | $24.49M | $250.50M | (m) | (m) | 2.27% | (m) | (m) |
| 2025-09-30 | (m) | $1.09B | $25.42M | $261.10M | (m) | (m) | 2.33% | (m) | (m) |
| 2025-06-30 | (m) | $1.12B | $24.89M | $276.66M | (m) | (m) | 2.22% | (m) | (m) |
| 2025-03-31 | (m) | $1.14B | $24.52M | $295.68M | (m) | (m) | 2.16% | (m) | (m) |
| 2024-12-31 | (m) | $1.13B | $22.89M | $289.61M | (m) | (m) | 2.03% | (m) | (m) |
| 2024-09-30 | (m) | $1.13B | $20.52M | $297.71M | (m) | (m) | 1.81% | (m) | (m) |
| 2024-06-30 | (m) | $1.13B | $19.31M | $308.52M | (m) | (m) | 1.71% | (m) | (m) |
| 2024-03-31 | (m) | $1.14B | $18.70M | $277.23M | (m) | (m) | 1.64% | (m) | (m) |
| 2023-12-31 | (m) | $1.10B | $18.11M | $264.37M | (m) | (m) | 1.65% | (m) | (m) |
| 2023-09-30 | (m) | $1.01B | $16.12M | $234.03M | (m) | (m) | 1.60% | (m) | (m) |
| 2023-06-30 | (m) | $906.48M | $14.78M | $197.73M | (m) | (m) | 1.63% | (m) | (m) |
| 2023-03-31 | (m) | $770.88M | $11.81M | $193.45M | (m) | (m) | 1.53% | (m) | (m) |
| 2022-12-31 | (m) | $688.37M | $10.63M | $174.75M | (m) | (m) | 1.54% | (m) | (m) |
| 2022-09-30 | (m) | $630.51M | $10.11M | $152.24M | (m) | (m) | 1.60% | (m) | (m) |
| 2022-06-30 | (m) | $561.39M | $9.20M | $121.71M | (m) | (m) | 1.64% | (m) | (m) |
| 2022-03-31 | (m) | $500.07M | $9.28M | $94.78M | (m) | (m) | 1.86% | (m) | (m) |
| 2021-12-31 | (m) | $438.59M | $8.62M | $75.43M | (m) | (m) | 1.97% | (m) | (m) |
| 2021-09-30 | (m) | $376.76M | $8.71M | $58.14M | (m) | (m) | 2.31% | (m) | (m) |
| 2021-06-30 | (m) | $321.19M | $8.83M | $49.93M | (m) | (m) | 2.75% | (m) | (m) |
| 2021-03-31 | (m) | $278.84M | $8.63M | $41.49M | (m) | (m) | 3.09% | (m) | (m) |
| 2020-12-31 | (m) | $348.57M | $8.60M | $70.04M | (m) | (m) | 2.47% | (m) | (m) |
| 2020-09-30 | (m) | $420.71M | $8.17M | $97.70M | (m) | (m) | 1.94% | (m) | (m) |
| 2020-06-30 | (m) | $521.73M | $7.63M | $132.27M | (m) | (m) | 1.46% | (m) | (m) |
| 2020-03-31 | (m) | $623.68M | $7.29M | $174.84M | (m) | (m) | 1.17% | (m) | (m) |
| 2019-12-31 | (m) | $628.41M | $7.00M | $183.15M | (m) | (m) | 1.11% | (m) | (m) |
| 2019-09-30 | (m) | (m) | $6.58M | $190.93M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $6.17M | $195.94M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | $5.55M | $190.98M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $4.70M | $177.70M | $3.60M | (m) | (m) | 49.43× | Reported |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $88.86M | $20.77M | (m) | (m) | 4.28× | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $361.00K | $10.62M | $20.23M | (m) | (m) | 0.52× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.